Solifenacin is a pharmaceutical active ingredient used in medications for overactive bladder and neurogenic detrusor overactivity. It is a ring-containing compound with moderate lipophilicity and no hydrogen bond donors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 242478-37-1
Solifenacin succinate
pharmaceutical raw material
Sodium diethyl oxalacetate
pharmaceutical raw material
Gabexate mesylate
pharmaceutical raw material
Alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride
pharmaceutical raw material
Denopamine
pharmaceutical raw material
Cannabidivarin
pharmaceutical raw material
Sodium ferulate
pharmaceutical raw material
Mycophenolic acid
pharmaceutical raw material
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
FBOUYBDGKBSUES-VXKWHMMOSA-N
C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5